BTIF Interest

Asset Description

Platform Name or Designation(Required)

Area(Required)

Subtype/Class(Required)

If targeted drug, what target(s)?(Required)

What is the biological premise to believe this asset will work in the intended indication(s)?(Required)

MOA(Required)

Briefly describe asset/platform’s mechanism.

Target Indication(s)(Required)

Current Phase of Development(Required)

If pre-clinical, is the asset fully IND enabled? If no, what is left to be done?(Required)

Data Readouts(Required)

Please summarize data that represents the “reason to believe” in this asset for the targeted indication(s).

What other competitors are in development competing with this asset?(Required)

Why is this asset different/superior to competitors in development for the same indication(s)?(Required)

FDA Support and Regulatory Milestones (e.g., breakthrough, orphan designations, etc.)(Required)

Company Overview(Required)

Please summarize company stats, history, university affiliations, etc.

List Key Publications(Required)

IP Summary(Required)

Please list key patents and types of patents.

KOLs Involved with the Company

Founders and/or who are on BoD or SAC.

Company Officers

Primary Contact Name(Required)

Prefix First Middle Last Suffix

Title/Role at Company(Required)

Email(Required)

Additional Officers (if applicable)

Website(Required)

Corporate Presentation Link

Company Funding History(Required)

Dilutive and non-dilutive, raised to date, rounds completed.

Major Funding Sources and Investors to Date(Required)

Cash on Hand(Required)

Runway (months)(Required)

Current Raise Underway(Required)

Investment Sought for Current Raise(Required)

Financing Progress (Committed Money and Investors)(Required)

Target Date for Close(Required)

What will financing be used for?(Required)

Summarize Reasons to Invest(Required)

CAPTCHA

Cookie Policy

Main Menu

MyTumorID®

Get Support Now

Research Advocacy